ST-2427

ST-2427 · SiteOne Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ST-2427, covering 2023-08-03 to 2023-08-03. Get the full timeline:

Most recent: Clinical Trial Update: Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ST-2427 [Phase 1]